KRYS

$0.00

(

+0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Krystal Biotech Inc

NASDAQ | KRYS

217.76

USD

+$0.00

(

+0.00%

)

At Close (As of Dec 2, 2025)

$6.32B

Market Cap

32.68

P/E Ratio

6.67

EPS

$221.84

52 Week High

$122.80

52 Week Low

HEALTHCARE

Sector

KRYS Chart

Recent Chart
Price Action

KRYS Technicals

Tags:

KRYS Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $270M
Total Revenue $291M
Cost Of Revenue $20M
Costof Goods And Services Sold $20M
Operating Income $66M
Selling General And Administrative $114M
Research And Development $54M
Operating Expenses $205M
Investment Income Net -
Net Interest Income $30M
Interest Income $30M
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $6.7M
Income Before Tax $95M
Income Tax Expense $6.2M
Interest And Debt Expense -
Net Income From Continuing Operations $89M
Comprehensive Income Net Of Tax -
Ebit $103M
Ebitda $110M
Net Income $89M

Revenue & Profitability

Earnings Performance

KRYS Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $1.1B
Total Current Assets $742M
Cash And Cash Equivalents At Carrying Value $345M
Cash And Short Term Investments $345M
Inventory $27M
Current Net Receivables $105M
Total Non Current Assets $314M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets -
Intangible Assets Excluding Goodwill -
Goodwill -
Investments -
Long Term Investments $152M
Short Term Investments $253M
Other Current Assets $13M
Other Non Current Assets -
Total Liabilities $109M
Total Current Liabilities $102M
Current Accounts Payable $5M
Deferred Revenue -
Current Debt -
Short Term Debt $1.2M
Total Non Current Liabilities $7.5M
Capital Lease Obligations $7.3M
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $7.3M
Other Current Liabilities $92M
Other Non Current Liabilities $1.4M
Total Shareholder Equity $946M
Treasury Stock -
Retained Earnings -$181M
Common Stock -
Common Stock Shares Outstanding $30M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow $123M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $6.7M
Capital Expenditures $4.2M
Change In Receivables -
Change In Inventory -$12M
Profit Loss -
Cashflow From Investment -$163M
Cashflow From Financing $27M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income $89M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $270M
Total Revenue $291M
Cost Of Revenue $20M
Costof Goods And Services Sold $20M
Operating Income $66M
Selling General And Administrative $114M
Research And Development $54M
Operating Expenses $205M
Investment Income Net -
Net Interest Income $30M
Interest Income $30M
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $6.7M
Income Before Tax $95M
Income Tax Expense $6.2M
Interest And Debt Expense -
Net Income From Continuing Operations $89M
Comprehensive Income Net Of Tax -
Ebit $103M
Ebitda $110M
Net Income $89M

KRYS News

KRYS Profile

Krystal Biotech Inc Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Krystal Biotech, Inc. is a clinical-stage biotechnology company based in Pittsburgh, Pennsylvania, focused on advancing redosable gene therapies for rare genetic diseases. Utilizing its proprietary Gene Delivery System and a strong pipeline of innovative therapies, the company seeks to provide durable solutions that enhance patient outcomes where few options exist. With a strategic emphasis on addressing significant unmet medical needs, Krystal Biotech is poised to become a transformative player in the biotechnology landscape, presenting a compelling opportunity for investors seeking exposure to cutting-edge medical advancements.

LPTX
+368.57%
$2.05
PAVS
-92.57%
$0.07
VHAI
0.00%
$0.00
BYND
-1.49%
$1.32
NVDA
+0.66%
$181.12
PLRZ
+129.65%
$7.25
FTEL
+17.50%
$1.41
CMND
-9.10%
$0.13
INTC
+7.69%
$43.08
PLUG
+12.77%
$2.16
IPG
-1.95%
$24.57
BITF
-0.15%
$3.27
ONDS
+11.12%
$8.42
AXDX
-61.36%
$0.03
NIO
-5.81%
$5.18
JSPR
+4.94%
$1.80
CHR
+4.81%
$0.04
TSLA
-0.95%
$426.04
ADAP
-15.14%
$0.05
BBD
+1.37%
$3.66
SOFI
+3.80%
$30.13
BMNR
+12.24%
$32.48
ASST
+4.33%
$1.09
AAL
+2.32%
$14.28
F
-1.48%
$12.96
SOND
-23.45%
$0.12
GOOGL
-1.65%
$314.89
RMBL
+60.50%
$3.21
LNW
-3.71%
$86.22
IREN
-8.17%
$44.52
ADD
-25.47%
$0.05
DNN
+3.17%
$2.60
BMNU
+23.61%
$7.59
YGMZ
-24.81%
$0.08
SRM
+53.27%
$10.30
CAN
-6.15%
$0.94
ACHR
+4.15%
$7.77
MARA
+4.87%
$12.08
AAPL
+1.09%
$286.21
ABEV
0.00%
$2.57
AMZN
+0.61%
$235.31
BTBT
+3.55%
$2.33
IVP
-5.04%
$0.12
BQ
+35.12%
$2.63
CLSK
+2.34%
$14.41
AMD
-1.83%
$215.72
PFE
-0.13%
$25.23
SGMO
+4.39%
$0.44
WLGS
-5.57%
$0.04
GOOG
-1.56%
$315.12
INHD
-14.77%
$0.14
PLTR
+2.14%
$171.08
MTSR
-0.35%
$70.50
PLTD
-2.21%
$6.93
WBD
+2.91%
$24.56
BTG
-3.57%
$4.43
EB
+79.03%
$4.44
EXK
-3.29%
$9.09
APLD
+2.83%
$29.01
CIFR
-3.68%
$18.96
ITUB
-1.41%
$7.69
MSFT
-1.07%
$486.74
AFMD
-34.94%
$0.18
MSTR
+9.04%
$186.92
RIVN
+1.72%
$17.45
ASBP
+3.94%
$0.10
BURU
+4.11%
$0.23
GPUS
+8.41%
$0.29
VALE
+0.98%
$12.81
RIG
+0.61%
$4.37
WULF
-3.21%
$14.80
BAC
+0.25%
$53.37
CDE
-1.79%
$16.96
VCIG
-6.34%
$0.98
TE
+8.49%
$4.47
ALIT
+3.89%
$2.36
CRWV
+1.07%
$77.89
NCT
-26.87%
$0.56
GRYP
-10.38%
$1.38
RGTI
+1.51%
$23.80
HOOD
+3.68%
$127.78
MODV
-25.22%
$0.43
TAOP
+23.83%
$2.65
STLA
+2.82%
$10.95
CGC
+0.44%
$1.13
MRVL
+1.84%
$92.78
BA
+9.79%
$204.72
SNAP
-0.06%
$7.63
SOUN
-0.46%
$11.46
GRAB
+0.18%
$5.28
KVUE
-1.33%
$16.99
BTE
-0.93%
$3.19
AG
+1.41%
$15.74
DRCT
-13.01%
$0.10
HBAN
+0.41%
$16.60
AKTX
-16.51%
$0.33
RIOT
+1.81%
$15.76
T
-0.98%
$25.53
JBLU
-2.18%
$4.47
TSLG
-1.06%
$9.17
LPTX
+368.57%
$2.05
PAVS
-92.57%
$0.07
VHAI
0.00%
$0.00
BYND
-1.49%
$1.32
NVDA
+0.66%
$181.12
PLRZ
+129.65%
$7.25
FTEL
+17.50%
$1.41
CMND
-9.10%
$0.13
INTC
+7.69%
$43.08
PLUG
+12.77%
$2.16
IPG
-1.95%
$24.57
BITF
-0.15%
$3.27
ONDS
+11.12%
$8.42
AXDX
-61.36%
$0.03
NIO
-5.81%
$5.18
JSPR
+4.94%
$1.80
CHR
+4.81%
$0.04
TSLA
-0.95%
$426.04
ADAP
-15.14%
$0.05
BBD
+1.37%
$3.66
SOFI
+3.80%
$30.13
BMNR
+12.24%
$32.48
ASST
+4.33%
$1.09
AAL
+2.32%
$14.28
F
-1.48%
$12.96
SOND
-23.45%
$0.12
GOOGL
-1.65%
$314.89
RMBL
+60.50%
$3.21
LNW
-3.71%
$86.22
IREN
-8.17%
$44.52
ADD
-25.47%
$0.05
DNN
+3.17%
$2.60
BMNU
+23.61%
$7.59
YGMZ
-24.81%
$0.08
SRM
+53.27%
$10.30
CAN
-6.15%
$0.94
ACHR
+4.15%
$7.77
MARA
+4.87%
$12.08
AAPL
+1.09%
$286.21
ABEV
0.00%
$2.57
AMZN
+0.61%
$235.31
BTBT
+3.55%
$2.33
IVP
-5.04%
$0.12
BQ
+35.12%
$2.63
CLSK
+2.34%
$14.41
AMD
-1.83%
$215.72
PFE
-0.13%
$25.23
SGMO
+4.39%
$0.44
WLGS
-5.57%
$0.04
GOOG
-1.56%
$315.12
INHD
-14.77%
$0.14
PLTR
+2.14%
$171.08
MTSR
-0.35%
$70.50
PLTD
-2.21%
$6.93
WBD
+2.91%
$24.56
BTG
-3.57%
$4.43
EB
+79.03%
$4.44
EXK
-3.29%
$9.09
APLD
+2.83%
$29.01
CIFR
-3.68%
$18.96
ITUB
-1.41%
$7.69
MSFT
-1.07%
$486.74
AFMD
-34.94%
$0.18
MSTR
+9.04%
$186.92
RIVN
+1.72%
$17.45
ASBP
+3.94%
$0.10
BURU
+4.11%
$0.23
GPUS
+8.41%
$0.29
VALE
+0.98%
$12.81
RIG
+0.61%
$4.37
WULF
-3.21%
$14.80
BAC
+0.25%
$53.37
CDE
-1.79%
$16.96
VCIG
-6.34%
$0.98
TE
+8.49%
$4.47
ALIT
+3.89%
$2.36
CRWV
+1.07%
$77.89
NCT
-26.87%
$0.56
GRYP
-10.38%
$1.38
RGTI
+1.51%
$23.80
HOOD
+3.68%
$127.78
MODV
-25.22%
$0.43
TAOP
+23.83%
$2.65
STLA
+2.82%
$10.95
CGC
+0.44%
$1.13
MRVL
+1.84%
$92.78
BA
+9.79%
$204.72
SNAP
-0.06%
$7.63
SOUN
-0.46%
$11.46
GRAB
+0.18%
$5.28
KVUE
-1.33%
$16.99
BTE
-0.93%
$3.19
AG
+1.41%
$15.74
DRCT
-13.01%
$0.10
HBAN
+0.41%
$16.60
AKTX
-16.51%
$0.33
RIOT
+1.81%
$15.76
T
-0.98%
$25.53
JBLU
-2.18%
$4.47
TSLG
-1.06%
$9.17
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.